Thomas Melchardt

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Heinz Gisslinger, Oleh Zagrijtschuk, Veronika Buxhofer‐Ausch et al. · Blood · 2015 · 184 citations · Full text

Life Sciences, Immunology, Pharmacology +9

A modified scoring of the <scp>NCCN</scp>‐<scp>IPI</scp> is more accurate in the elderly and is improved by albumin and β₂‐microglobulin

Thomas Melchardt, Katharina Troppan, Clemens Hufnagl et al. · British Journal of Haematology · 2014 · 89 citations

Medicine, Geriatric Medicine, Cancer Immunology +15

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

Katharina Troppan, Konstantin Schlick, Alexander Deutsch et al. · British Journal of Cancer · 2014 · 76 citations · Full text

Medicine, Immunology, Oncology +15

αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer

Anna S. Berghoff, Astrid Kerstin Kovanda, Thomas Melchardt et al. · Clinical & Experimental Metastasis · 2014 · 67 citations

Medicine, Cell Biology, Oncology +16

Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia

Thomas Melchardt, Alexander Egle, Christoph Grabmer et al. · Cancer · 2010 · 65 citations · Full text

Life Sciences, Immunology, Oncology +17